Abstract
Studies utilizing xenograft mouse models have shown that plasma applied to the skin overlying tumors results in their shrinkage. Plasma is considered a non-penetrating treatment; however these studies demonstrate plasma effects beyond the postulated depth of physical penetration of plasma components. The present study examines the propagation of plasma effects through a tissue model using 3-D, cell-laden extracellular matrices (ECM). These matrices are used as barriers against direct plasma penetration. By placing them onto a monolayer of target cancer cells to create an in-vitro analogue to the in-vivo studies, we distinguished between cellular effects from direct plasma exposure and cellular effects due to cell-to-cell signaling stimulated by plasma. We show that nanosecond pulsed dielectric barrier discharge (nspDBD) plasma treatment applied atop an acellular barrier impedes the externalization of Calreticulin (CRT) in the target cells. In contrast, when a barrier is populated with cells, CRT externalization is restored. Thus, we demonstrate that plasma components stimulate signaling between cells embedded in the barrier to transfer plasma effects to the target cells.